20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver,Canada

Track 1:  Diabetes Pathophysiology

Diabetes usually referred as diabetes mellitus, describes a group of metabolic diseases. Diabetes occurs when there is a dis-balance between the demand and supply of the hormone named insulin. This wide topic is being discussed in ADA Meetings. There are different types of diabetes and all types are treatable and manageable as discussed earlier in European Diabetes.  Pathophysiology of diabetes leads to autoimmune disease and it’s also known as IDDM, whereas it can also lead to the Peripheral insulin resistance and also known as NIDDM or “adult onset” diabetes. Pathophysiology of gestational diabetes is also one of the types which develop high blood sugar levels in pregnant women who don’t have any previous history of Diabetes. Every few years, the  metabolic syndromes like diabetes is  re-evaluates by community  the present recommendations for the classification, diagnosis, and screening of diabetes, reflecting new info from research and clinical practice which facilitates understanding current hindrance and treatment choices and cost effectiveness in treatment and management of Diabetes as told in ADA Sessions.

Related Conferences:

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia;  13^th Global Diabetes Conference & Medicare Expo, UK ;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue BiologyFebruary 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue BiologyFebruary 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK.

Track 2:  Pediatric Diabetes

Pediatrics is the field of medicine that is concerned with the health of infants, children, and adolescents; their growth and development; and their chance to attain full potential as adults. General medicine includes the essential treatments concerned for the betterment of pediatric health. The most significant problems can be due to nutritional deficiencies to the overall health of infants and kids as a result of growth and development is seriously hindered by shortages in essential vitamins or nutrients. The aim of the study of pediatrics is to reduce infant and child rate of deaths, management the unfold of communicable disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents. It can be acknowledged that this can be reached by learning the major and primary subject on Pediatrics.
 

Related Conferences:

Pediatrics Conferences September 14-16, 2016 Amsterdam, The Netherlands; Pediatric Surgery Conferences September 14-16, 2016 Amsterdam, Netherlands; Pediatric Dermatology Conferences October 10-11, 2016 Manchester, UK; Neonatology Conferences November 14-16, 2016 Valencia, Spain; Neonatal Conferences November 14-16, 2016 Valencia, Spain; Pediatric Neurology Conference November 14-16, 2016 Valencia, Spain; 90th Annual Meeting of the Canadian Pediatric Society Jun 22-25 2016 Canada; 28th International Pediatric Association Congress of Pediatrics Aug 17-22 2016, Canada; 2016 American Academy of Pediatrics National Conference & Exhibition October 22-25 2016, USA; 15th Asian Pacific Congress of Pediatrics January 21-24 2016, India; 6^th Congress of the European Academy of Pediatric Societies October 21-25 2016, Switzerland.

Track 3:  Symptoms and Management of Diabetes

The supervision of diabetes has been resolutely grounded in scientific advances that endure to stipulate our understanding of the pathophysiology of diabetes and direct our selection in selecting optimal therapies for type 1 and type 2 diabetes. Common risk factors or symptoms of Diabetes include increased weight, blood pressure, cholesterol and triglyceride (blood fat) levels. The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations.

Related Conferences:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th InternationalConference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Track 4: Diabetes Complications

The Diabetic Complications chiefly includes injurious effects of hyperglycemia which are primarily separated into macro vascular complications and micro vascular complications. Macro vascular complication chiefly includes retinopathy and micro vascular includes neuropathy. Diabetic retinopathy is also the foremost common micro vascular complication of diabetes. It is responsible for ∼ 10,000 new cases of blindness every year in the United States alone. The risk of developing diabetic retinopathy or other micro vascular complications of diabetes depends on both the duration and the severity of hyperglycemia. Diabetic nephropathy is the leading cause of renal failure in the United States. It is defined by proteinuria > 500 mg in 24 hours within the setting of diabetes; however this can be preceded by lower degrees of proteinuria, or “micro albuminuria.

Related Conferences:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th InternationalConference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Track 5: Diabetic Medicare and its Advantages

Diabetic Medicare covers the fasting blood glucose test, which is a diabetes screening. Medicare covers two diabetes screenings each year for beneficiaries who are at high risk for diabetes. High risk factors for diabetes include: high blood pressure, history of abnormal sterol and triglyceride levels, obesity, or a history of high glucose. If this disorder runs in your family, you additionally may also need regular diabetes testing. Diabetic Medicare may include Therapeutic shoe, Glucose control solution or Lancet devices or Lancets as prescribed by your doctor.

Related Conferences:

Diabetes Conferences Europe September 15-17, 2016, Germany; 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, UAE; International Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA; 11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia; 9thGlobal Diabetologists Annual Meeting and Medicare Expo, June 06-08, 2016, USA; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE 

Track 6: Diabetic Nutrition

Diabetic Nutrition or Diabetic diet refers to the diet that is recommended for people with diabetes mellitus, or high blood glucose. There is abundant disagreement relating to what this diet ought to accommodate. Since carbohydrate is the macronutrient which raises blood glucose levels most importantly, the greatest debate is regarding how low in carbohydrates the diet ought to be. This is because although lowering carbohydrate intake will lead to reduced blood glucose levels, but as we know it is the best source of calories too and hence one can improve the health in a big way just by making small changes to the diet, while still enjoying their favorite foods. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories (carbohydrates too). Manufacturers are now keen towards Diabetes Nutrition on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy consumption and facilitate diabetes prevention and its concomitant risk factors.

Related Conferences:

6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, UAE; International Conference on Thyroid Disorders and Treatment, February 29-March 02, 2016, USA; 11th Asia Pacific Diabetes Conference and Expo, July 11-13, 2016, Australia; 9th Global Diabetologists Annual Meeting and Medicare Expo, June 06-08, 2016, USA; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics, October 17-19, 2016, Malaysia; Advanced Technologies & Treatments for Diabetes conference, Milan, Italy; New Therapeutics for Diabetes and Obesity conference, La Jolla, United States; Primary Care Update: Type 2 Diabetes, Metabolic Syndrome and Obesity Baltic Cruise conference, Copenhagen, Denmark; International Conference on Diabetes and Nutrition conference, Toronto Canada; Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies conferences, Japan.

Track 7: Diabetes and Metabolism

The metabolism of individuals with diabetes differs to the metabolism of individuals without it. In type 2 diabetes, the effectiveness of insulin is reduced and in type 1 diabetes, insulin levels in the body are terribly low. For this reason only, type 1 diabetes requires insulin delivery from other strategies. Insulin resistance, commonest in pre-diabetes. Metabolic syndrome and type 2 diabetes, impairs the body’s ability to metabolize glucose. The metabolism of people with diabetes is sort of similar to the metabolism of people without diabetes. The sole distinction is the volume and/or effectiveness of the insulin produced by the body. There is a selected organic process by which insulin is produced inside the body of person.  Insulin therapy is usually recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent.  Insulin therapy is also initiated as augmentation, beginning at 0.3 units per kg, or as replacement, beginning at 0.6 to 1.0 units per kg. Glucose control, adverse effects, cost, adherence, and quality of life ought to be thought of once selecting Medicare. Metformin should be continued if possible because it is proven to reduce all-cause mortality and cardiovascular events in overweight patients with diabetes. Titration of insulin over time is critical to improving glycemic management and preventing diabetes related complications.

Related Conferences:

15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; 14^th International Conference on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; Diabetes Congress Dubai November 14-16 2016, UAE; International Conference ON Ayurvedic & Herbal Medicine for Diabetes October 9-11 2015, USA; ;  International Conference on Metabolic Syndromes October 17-18, 2016,Italy; Diabetes Conferences Europe September 15-17, 2016, Germany; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 8: Alternative Treatment: Medicine and Therapies

Diabetes mellitus is a metabolic disorder in the endocrine system. This dreadful disease is found in all parts of the planet and turning into a significant threat of group health. There are countless chemical agents available to regulate and to treat diabetic patients, but total recovery from diabetes has not been according to the current date. Additionally to adverse effects, drug treatments don’t seem to be continually satisfactory in maintaining euglycemia and avoiding late stage diabetic complications. Alternative to these artificial agents, plants provided a potential supply of hypoglycemic drugs and are widely utilized in many ancient system to prevent diabetes. Several medicinal plants have been investigated for their beneficial effect in numerous types of diseases. Other alternative therapies such as dietary supplements, acupuncture, hydrotherapy, and yoga therapies less likely to have the side effects of typical approaches for diabetes. About one-third of people with diabetes use some form of complementary and alternative medicine (CAM) therapies, according to an article published in the journal Clinical Diabetes. “Integrative medicine” is a term for the combination of ancient medicine and CAM therapies. CAM treatments are recognized to ease the suffering of many of the individuals  with chronic diseases, together with diabetes. However, before subscribing to any of the alternative therapies, it is necessary to consult your health care team and your doctor.

Related Conference:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France 

Track 9: Advancement in Diabetic Treatment and Diagnosis

There are so many advancements in Diabetic Treatment and Diagnosis but when one is dealing with the day to day management of Diabetes, it may seem slow or too slow. There are many tools which help you to maintain Diabetes like what you eat, what your blood sugar levels are, how much you exercise and how much you feel each day, some of these include smartphones, tablets to note your blood sugar or meal and snacks, devices that test your sugar levels every minute, “Smart Pumps” that give you insulin as you need and furthermore mails or message which can remind you to have regular checkups. Indeed, it may be argued that the key advances in type 1 Diabetic care created inside the half-moon of a century have come back from technology instead of biology. At a similar time, not all new technologies succeed (e.g. the Glucowatch). patients and their attention suppliers can before long see a series of additional advanced medical technologies utilized in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of rising the lives of these with the disease.

Related Conference:

15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; 14^th International Conference on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; Diabetes Congress Dubai November 14-16 2016, UAE; International Conference ON Ayurvedic & Herbal Medicine for Diabetes October 9-11 2015, USA; ;  International Conference on Metabolic Syndromes October 17-18, 2016,Italy; Diabetes Conferences Europe September 15-17, 2016, Germany; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 10: Energy Balance, Obesity and Diabetes

A study was done to see the combined effect of the components of energy balance (energy intake and physical activity) and the development of Type 2 Diabetes and the aim of the study is to examine the components of energy balance and the incidence of Type 2 Diabetes in a cohort of middle-aged women. This study was done on a population of 64,227 middle aged Chinese women who don’t have any prior history of Diabetes or any chronic Disease. They collected all the data on diet and physical activity habits and they found that Body Mass index (BMI) and weight gain (since age 20) was strongly associated with type 2 Diabetes incidences. They also concluded that Energy Intake (EI) was associated with modestly increased risk, while physical activity (PA) was associated with decreased risk of type 2 Diabetes, less active women with higher EI and higher risk of type 2 diabetes than active women with lower EI. The EI to PA ratio (EI:PA) was positively associated with Type 2 Diabetes risk. This study suggests that energy balance plays an important role in type 2 Diabetes and this effect may be modified by BMI. 

Related Conference:

16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016, Malaysia; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Endocrinology Conferences October 10-12, 2016 Manchester, UK; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France.

Track 11: Diabetes Science and Technology

The concept of and new discovery and emerging therapies like  reverse diabetes for the treatment of diabetes has expanded in recent years. There is a lot of latest research on diabetes happening and elaborated at IDF diabetes 2016 and the latest includes some very rare forms of diabetes which are caused by single gene mutations. They are called "monogenic" forms of diabetes and new research is opening the door to specific treatments for these patients. With the advanced  type1 diabetes treatment  various devices e.g. insulin pumps which is used for the administration of insulin , rapid HbA1c monitoring, insulin pen, biomarkers, biostator, artificial pancreas and etc. are formed for the treatment. Number of innovation and treatment are increasing with the increase in research work by Research and development department in various sectors and endocrinology is getting treatment with these devices. Continuous Glucose Monitoring (CGM) is a relatively new technology which has the potential to assist people living with type 1 or type 2 Diabetes and treated with insulin to achieve the goal of optimum control of blood glucose. This will remove the diabetes cholesterol.

Related Conference:

Diabetes Conferences Europe September 15-17, 2016, Germany ; International Conference on AleternativeAyurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12^th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86^th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5^th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16^th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference onNutrition and Growth March 17-19 2016, Austria;Diabetes Conferences Europe September 15-17, 2016, Germany, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK.

Track 12: Present Scenario and Risk Factor of Diabetes